SenesTech, Inc. (SNES): Price and Financial Metrics

SenesTech, Inc. (SNES): $0.40

0.02 (-3.61%)

POWR Rating

Component Grades








SNES Price/Volume Stats

Current price $0.40 52-week high $11.20
Prev. close $0.42 52-week low $0.37
Day low $0.39 Volume 58,536
Day high $0.42 Avg. volume 148,712
50-day MA $0.69 Dividend yield N/A
200-day MA $1.69 Market Cap 821.20K

SNES Stock Price Chart Interactive Chart >


  • SNES scores best on the Growth dimension, with a Growth rank ahead of 80.17% of US stocks.
  • SNES's strongest trending metric is Momentum; it's been moving down over the last 58 days.
  • SNES ranks lowest in Stability; there it ranks in the 0th percentile.

SNES Stock Summary

  • SENESTECH INC's market capitalization of $1,319,196 is ahead of merely 0.22% of US-listed equities.
  • In terms of volatility of its share price, SNES is more volatile than 95.46% of stocks we're observing.
  • SENESTECH INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -411.39%, greater than the shareholder yield of just 1.65% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to SENESTECH INC, a group of peers worth examining would be ECOR, MYSZ, AWH, RWLK, and LUNA.
  • SNES's SEC filings can be seen here. And to visit SENESTECH INC's official web site, go to

SNES Valuation Summary

  • SNES's EV/EBIT ratio is 0; this is 100% lower than that of the median Basic Materials stock.
  • Over the past 82 months, SNES's price/earnings ratio has gone up 4.4.

Below are key valuation metrics over time for SNES.

Stock Date P/S P/B P/E EV/EBIT
SNES 2023-09-06 1.6 0.6 -0.2 0
SNES 2023-09-05 1.5 0.6 -0.2 0
SNES 2023-09-01 1.6 0.6 -0.2 0
SNES 2023-08-31 1.6 0.6 -0.2 0
SNES 2023-08-30 1.6 0.6 -0.2 0
SNES 2023-08-29 1.6 0.6 -0.2 0

SNES Growth Metrics

    Its 5 year revenue growth rate is now at -49.37%.
  • The 4 year net cashflow from operations growth rate now stands at -19.19%.
  • The 3 year price growth rate now stands at -98.5%.
Over the past 18 months, SNES's revenue has gone up $558,000.

The table below shows SNES's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.891 -8.113 -10.041
2022-06-30 0.824 -7.926 -9.648
2022-03-31 0.707 -7.793 -8.779
2021-12-31 0.6 -7.779 -8.268
2021-09-30 0.528 -7.645 -7.868
2021-06-30 0.422 -7.536 -7.534

SNES Price Target

For more insight on analysts targets of SNES, see our SNES price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.00 Average Broker Recommendation 1.5 (Moderate Buy)

SenesTech, Inc. (SNES) Company Bio

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It develops a pipeline of fertility control and animal health products, such as ContraPest, plant-based fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is based in Flagstaff, Arizona.

SNES Latest News Stream

Event/Time News Detail
Loading, please wait...

SNES Latest Social Stream

Loading social stream, please wait...

View Full SNES Social Stream

Latest SNES News From Around the Web

Below are the latest news stories about SENESTECH INC that investors may wish to consider to help them evaluate SNES as an investment opportunity.

ContraPest® Deploying at Waste Water Treatment Facilities

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that ContraPest is being deployed into a new vertical, waste water treatment facilities, with deployments in both Washington and California.

Yahoo | September 11, 2023

SenesTech Announces Closing of Warrant Exercise for $2.1 Million in Gross Proceeds

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of its previously announced exercise of certain existing warrants to purchase 2,934,575 shares of its common stock at a reduced exercise price of $0.7202 per share. In addition, the Company issued new warrants, as described below. The aggregate gross proceeds from the exe

Yahoo | August 29, 2023

Q2 2023 Senestech Inc Earnings Call

Q2 2023 Senestech Inc Earnings Call

Yahoo | August 11, 2023

SenesTech Announces Second Quarter 2023 Financial Results

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023.

Yahoo | August 10, 2023

SenesTech to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on Thursday, August 10, 2023. The Company has scheduled a conference call that same day, Thursday, August 10, 2023, at 5:00 pm ET, to review the results.

Yahoo | August 3, 2023

Read More 'SNES' Stories Here

SNES Price Returns

1-mo -35.48%
3-mo -65.52%
6-mo -73.15%
1-year -95.34%
3-year -98.74%
5-year -99.86%
YTD -87.06%
2022 -84.22%
2021 -43.26%
2020 -84.32%
2019 -5.98%
2018 -18.75%

Continue Researching SNES

Want to see what other sources are saying about SenesTech Inc's financials and stock price? Try the links below:

SenesTech Inc (SNES) Stock Price | Nasdaq
SenesTech Inc (SNES) Stock Quote, History and News - Yahoo Finance
SenesTech Inc (SNES) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!